About i.Bioceuticals
i.Bioceuticals was founded in 2009 and is based in Orleans, United States. Operations are focused on the production of pine bark extracts within the nutraceutical industry. Natural ingredients are processed through extraction methods to support health-related applications. The company is led by CEO Olivier Fahy, with activities centered on manufacturing for various markets. Geographic emphasis remains on domestic production facilities.
- Headquarter Orleans, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Groupe Berkem
(Feb 16, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of i.Bioceuticals
Detailed funding history for i.Bioceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in i.Bioceuticals
i.Bioceuticals has secured backing from 1 investor. Prominent investors backing the company include Groupe Berkem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of natural active ingredients and plant extracts for cosmetics and food industries
|
Locked | Locked | Locked |
Investor details for i.Bioceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by i.Bioceuticals
Investment portfolio details for i.Bioceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - i.Bioceuticals
Detailed financials for i.Bioceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
I.Bioceuticals Comparisons
Peer comparison for i.Bioceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of i.Bioceuticals
Detailed competitors of i.Bioceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on I.Bioceuticals
Complete news archive for i.Bioceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about i.Bioceuticals
i.Bioceuticals was founded in 2009.
i.Bioceuticals is headquartered in Orleans, United States. It is registered at Orleans, Massachusetts, United States.
Olivier Fahy is the current CEO of i.Bioceuticals.
i.Bioceuticals was founded in 2009 and is based in Orleans, United States. Operations are focused on the production of pine bark extracts within the nutraceutical industry. Natural ingredients are processed through extraction methods to support health-related applications. The company is led by CEO Olivier Fahy, with activities centered on manufacturing for various markets. Geographic emphasis remains on domestic production facilities.
i.Bioceuticals has 1 investor. Key investors include Groupe Berkem.